Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neuroendocrine Tumors 13Meningioma 6Paraganglioma 5Neuroblastoma 5Pheochromocytoma 4Carcinoid Tumor 4von Hippel-Lindau Disease 3Medulloblastoma 3Prostatic Neoplasms 2Oncogenic osteomalacia 2Neuroectodermal Tumors, Primitive 2Multiple Endocrine Neoplasia Type 1 2Gastro-enteropancreatic neuroendocrine tumor 2Tumor Positron-Emission Tomography 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Pinealoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma, Acoustic 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia 1Metastatic Neuroendocrine Prostate Cancer 1Kidney Neoplasms 1Hypoglycemia 1Hypertension 1Hyperparathyroidism 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 387Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × gallium Ga 68 dotatate × Clear all
NCT04529044 2025-10-30

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

OHSU Knight Cancer Institute

Phase 2 Not yet recruiting
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡